for eMaxHealthType 2 Diabetes Drug
Rimonabant Lowers Blood Glucose and Reduces Weight, Waist Size, and Lipid Problems
A novel drug has demonstrated that it can help multiple problems associated with type 2 diabetes by lowering blood glucose and reducing weight and waist circumference, as well as modifying the disordered lipids associated with diabetic dyslipidemia, according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.
"Results of the RIO-Diabetes (Rimonabant In Obesity) study show impressive findings in all aspects of the trial, especially in glycemic control and improvement in the lipid profile, in part explained by weight loss and in part independent of weight loss, suggesting that rimonabant may exert direct metabolic effects in type 2 diabetes," said Andr
eMaxHealth welcomes yourcomments and feedback on this story without registration, but keep the comments meaningful please. Links are not accepted.
